Belgian sleep apnea device reimbursements rise 10% to 207,000 in 2025

Belgian health insurer Riziv reports a nearly 10% year-on-year increase in reimbursed sleep apnea devices, reaching 207,000 in 2025. The rise reflects growing diagnosis rates and cultural normalization, though the item offers no data on underlying health outcomes or cost implications.